Monitor BLM approval status and any subsequent drilling or reserve reports. The speculative pivot to oil and gas may drive volatility, but lack of proven reserves and regulatory uncertainty limit near-term catalysts.
Price Chart
Executive Summary
Bioforce Nanosciences received an assignment of 19,957 acres of federal oil and gas leases in Nevada from its majority shareholder, pending BLM approval. The company is pivoting from vitamin supplements to oil and gas exploration, but no proven reserves or pilot wells exist, making this a highly speculative asset acquisition.
Key Facts
- Assignment of 11 federal oil and gas leases covering ~19,957 acres in Nye County, Nevada
- Assignment from Natural Minerals Trust, LLC (controlled by majority shareholder Nexus Capital Investments)
- Pending BLM approval with no assurance of grant
- 12.5% federal royalty on gross production if developed
- No proven reserves established and no pilot wells drilled
- Engaged Ryder Scott for reserve evaluation on July 1, 2026
- Company previously announced strategic pivot from vitamin supplements to oil and gas
Financial Impact
No financial figures disclosed; 12.5% royalty on future production if developed, but no proven reserves or revenue from leases
Risk Factors
- BLM approval may not be granted
- No proven reserves or pilot wells; development may not be commercially viable
- Company has no history in oil and gas operations
- Majority shareholder control may create conflicts of interest
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001091818-26-000087 |
| Document: 0001091818-26-000087-index-headers.html | 0001091818-26-000087 |
| Document: 0001091818-26-000087-index.html | 0001091818-26-000087 |
| Document: 0001091818-26-000087.txt | 0001091818-26-000087 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 8-K | $8.89 | awaiting T+20 | — | $7.95 (−10.57%) |
Sep 4, 2026 7w ago | 8-K | $6.10 $7.01 | ▼ −14.92% | ▼ −14.07% | $7.95 (−30.33%) |
Aug 18, 2026 9w ago | 8-K | $3.84 $10.01 | ▲ +160.68% | ▲ +161.67% | $7.95 (+107.03%) |
Aug 14, 2026 10w ago | 8-K | $3.40 $9.71 | ▲ +185.59% | ▲ +187.58% | $7.95 (+133.82%) |
Jul 7, 2026 15w ago | 8-K | $2.02 $1.85 | ▼ −8.42% | ▼ −11.57% | $7.95 (+293.56%) |
Jul 1, 2026 16w ago | 8-K | $1.69 $1.90 | ▲ +12.43% | ▲ +12.97% | $7.95 (+370.41%) |
Jun 18, 2026 18w ago | 8-K | $1.79 $1.50 | ▼ −16.20% | ▼ −15.58% | $7.95 (+344.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers